Section Arrow
NSPR.NASDAQ
- InspireMD
Quotes are at least 15-min delayed:2026/05/01 01:58 EDT
Regular Hours
Last
 1.18
+0.04 (+3.51%)
Day High 
1.2399 
Prev. Close
1.14 
1-M High
1.7226 
Volume 
69.70K 
Bid
1.15
Ask
1.32
Day Low
1.15 
Open
1.15 
1-M Low
1.12 
Market Cap 
53.35M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.27 
20-SMA 1.34 
50-SMA 1.57 
52-W High 2.9319 
52-W Low 1.12 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.76/-0.94
Enterprise Value
55.58M
Balance Sheet
Book Value Per Share
1.18
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
8.98M
Operating Revenue Per Share
0.12
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PMIPicard Medical Inc0.455-0.0186-3.93%-- 
BSXBoston Scientific Corp57.61+0.46+0.80%29.46PE
ABTAbbott Laboratories90.79-0.54-0.59%24.55PE
MDTMedtronic plc80.97+1.6+2.02%22.17PE
QSIQuantum-Si0.9806+0.1158+13.39%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.